These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33431411)

  • 1. Structural and Biochemical Characterization of the Novel CTX-M-151 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam.
    Ghiglione B; Rodríguez MM; Brunetti F; Papp-Wallace KM; Yoshizumi A; Ishii Y; Bonomo RA; Gutkind G; Klinke S; Power P
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33431411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Landscape of Diazabicyclooctane (DBO) Inhibition: Avibactam Inactivation of PER-2 β-Lactamase.
    Ruggiero M; Papp-Wallace KM; Taracila MA; Mojica MF; Bethel CR; Rudin SD; Zeiser ET; Gutkind G; Bonomo RA; Power P
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Insights into the Inhibition of the Extended-Spectrum β-Lactamase PER-2 by Avibactam.
    Ruggiero M; Papp-Wallace KM; Brunetti F; Barnes MD; Bonomo RA; Gutkind G; Klinke S; Power P
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Insights into the TLA-3 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam and OP0595.
    Jin W; Wachino JI; Yamaguchi Y; Kimura K; Kumar A; Yamada M; Morinaka A; Sakamaki Y; Yonezawa M; Kurosaki H; Arakawa Y
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Substrate Specificity in the CTX-M Family: the Role of Asp240 in Ceftazidime Hydrolysis.
    Ghiglione B; Rodríguez MM; Curto L; Brunetti F; Dropa M; Bonomo RA; Power P; Gutkind G
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N
    Ourghanlian C; Soroka D; Arthur M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.
    Pemberton OA; Noor RE; Kumar M V V; Sanishvili R; Kemp MT; Kearns FL; Woodcock HL; Gelis I; Chen Y
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5818-5825. PubMed ID: 32123084
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from
    Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM
    ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985
    [No Abstract]   [Full Text] [Related]  

  • 12. Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase Inhibition.
    Hinchliffe P; Tooke CL; Bethel CR; Wang B; Arthur C; Heesom KJ; Shapiro S; Schlatzer DM; Papp-Wallace KM; Bonomo RA; Spencer J
    mBio; 2022 Jun; 13(3):e0179321. PubMed ID: 35612361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs.
    Fröhlich C; Sørum V; Thomassen AM; Johnsen PJ; Leiros HS; Samuelsen Ø
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30918055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Amino Acid Substitutions Leading to CTX-M-15-Mediated Resistance to the Ceftazidime-Avibactam Combination.
    Compain F; Dorchène D; Arthur M
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a Ceftazidime-Avibactam combination in a murine model of Septicemia caused by Enterobacteriaceae species producing ampc or extended-spectrum β-lactamases.
    Levasseur P; Girard AM; Lavallade L; Miossec C; Pace J; Coleman K
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6490-5. PubMed ID: 25136016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases.
    Levasseur P; Girard AM; Miossec C; Pace J; Coleman K
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1931-4. PubMed ID: 25583732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
    Doublet B; Granier SA; Robin F; Bonnet R; Fabre L; Brisabois A; Cloeckaert A; Weill FX
    Antimicrob Agents Chemother; 2009 May; 53(5):1944-51. PubMed ID: 19273683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reclaiming the efficacy of β-lactam-β-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidime.
    Papp-Wallace KM; Winkler ML; Gatta JA; Taracila MA; Chilakala S; Xu Y; Johnson JK; Bonomo RA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4290-7. PubMed ID: 24820081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain.
    Giani T; Cannatelli A; Di Pilato V; Testa R; Nichols WW; Rossolini GM
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):83-5. PubMed ID: 27394638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.